Product Images Gentamicin Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gentamicin Sulfate NDC 51662-1597 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

POUCH - 51662 1597 2 Pouch Label

POUCH - 51662 1597 2 Pouch Label

Gentamicin Sulfate Injection is a medication that comes in a 2L vial and contains 80mg/2mL (48mg/nL). The product contains NET He x:ylylparaben and TSoke E. The medication should be stored at 20-25% capacity. The provided text also contains an identification code of Siee2 13972 and a prescription number of ORICINAL NFG O+ 8489-1207-83.*

CASE - 51662 1597 3 Case Label

CASE - 51662 1597 3 Case Label

Gentamicin Sulfate Injection is a medication that comes in vials of 2mL each and is sold in batches of 25. It has a strength of 80mg/2nL, which is equivalent to 40mg/mL. The medication is also referred to as Gentan Is Insase, and is dissolved in a solution containing sodium tartrate, hydroxide, and water. Its application may require supervision by a qualified physician or pharmacist.*

SERIALIZED RFID LABEL - 51662 1597 3 Serialized RFID LAbel

SERIALIZED RFID LABEL - 51662 1597 3 Serialized RFID LAbel

BOXED WARNING - Boxed

BOXED WARNING - Boxed

This text provides warnings and precautions for the use of Gentamicin Sulfate Injection, USP, a type of aminoglycoside antibiotic. Patients receiving this medication should be closely monitored for potential toxicity, such as nephrotoxicity and neurotoxicity. Patients with impaired renal function and receiving high dosage or prolonged therapy are at a greater risk. Renal and eighth cranial nerve function should be monitored, and serum concentrations of aminoglycosides should be monitored to avoid potential toxic levels. Concurrent use of potentially neurotoxic or nephrotoxic drugs should be avoided. The use of gentamicin with potent diuretics should also be avoided as it may cause ototoxicity. Aminoglycosides can cause fetal harm when administered to pregnant women.*

DOSAGE 2 - Dosage 2

DOSAGE 2 - Dosage 2

DOSAGE 1 - Dosage

DOSAGE 1 - Dosage

This is a dosage schedule guide for adults with normal renal function. It provides dosages for various patient weights, ranging from 20 mg/mt to 225 mg/kg, to be administered at eight-hour intervals. The guide is specifically designed for the treatment of serious and life-threatening infections. The dosage amounts are provided as usual doses and doses for when the infection becomes severe. The table also indicates that the dosage of aminoglycoside should be recalculated periodically.*

STRUCTURE - Structure

STRUCTURE - Structure

VIAL LABEL - Vial Lable

VIAL LABEL - Vial Lable

This is a description of a 2mL single-dose injection of Gentamicin Sulfate in USP, containing 80 mg/2 mL (40 mg/mL as Gentamicin) for L.V. or LM. use. It must be diluted for intravenous use. The NDC number is 0409-1207-13 and the product has Lot/Exp area (8VP).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.